Kennedy Capital Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.65M Buy
34,526
+2,477
+8% +$381K 0.12% 268
2025
Q4
$5.58M Buy
32,049
+1,695
+6% +$309K 0.12% 276
2025
Q3
$4.37M Buy
30,354
+8,457
+39% +$1.04M 0.1% 319
2025
Q2
$2.2M Sell
21,897
-12,500
-36% -$956K 0.05% 430
2025
Q1
$2.62M Sell
34,397
-1,661
-5% -$127K 0.06% 397
2024
Q4
$2.49M Buy
36,058
+23,940
+198% +$1.72M 0.06% 480
2024
Q3
$885K Buy
12,118
+2,021
+20% +$149K 0.02% 603
2024
Q2
$676K Buy
10,097
+238
+2% +$9.23K 0.01% 622
2024
Q1
$267K Buy
+9,859
New +$276K 0.01% 686

Other funds holding INSM

Kennedy Capital Management's INSM Position: Q1 2026 in Review

Kennedy Capital Management increased its Insmed (INSM) stake by 7.7% in Q1 2026, buying an estimated $381K and bringing the position to 34,526 shares worth $5.65M. The position accounts for 0.12% of the portfolio, ranked #268.

Kennedy Capital Management first reported a position in INSM in Q1 2024 and has held it in 9 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Kennedy Capital Management held 34,526 shares of Insmed worth $5.65M as of Q1 2026.
  • Kennedy Capital Management bought 2,477 Insmed shares in Q1 2026, an estimated $381K.
  • Insmed made up 0.12% of Kennedy Capital Management's portfolio in Q1 2026, its #268 holding.
  • Kennedy Capital Management first reported a position in Insmed in Q1 2024 and has held it in 9 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.